📰 Precision Motion News
Page 2 - Precision Motion News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Precision Motion. Real-time updates on events, politics, business and more.
April 23, 2023
TLG Acquisition One (NYSE:TLGA – Get Rating) and Novanta (NASDAQ:NOVT – Get Rating) are both oils/energy companies, but which is the better investment? We will contrast the two companies based on the strength of their dividends, risk, earnings, valuation, analyst recommendations, institutional ownership and profitability. Institutional & Insider Ownership 68.6% of TLG Acquisition One shares […]
April 5, 2023
Toronto, ON (PRWEB) April 05, 2023 -- This webinar will discuss key considerations for instrument selection, data quality assurance and innovative enabling
March 7, 2023
Operator: Good morning. My name is Keith, and I will be your conference operator today. At this time, I would like to welcome everyone to Novanta Inc. 2022 Fourth Quarter and Full Year Earnings Call.
January 28, 2023
PI provides linear, rotary, planar, motorized stages, and custom solutions for research and industrial applications. • Vibrationless motion.
December 30, 2022
Operator: Good morning. My name is Keith, and I will be your conference operator today. At this time, I would like to welcome everyone to the Novanta Inc. 2022 Third Quarter Earnings Call.
November 23, 2022
The global robotics market was worth $27.73 billion in 2020 and is forecasted to reach $74.1 billion by 2026, indicating a CAGR of 17.45% during the period of 2021 to 2026.
November 2, 2022
New data shows Clario has helped more than 2.6 million patients participate in life changing clinical trials for innovative new medicines through decentralized and hybrid technology solutions More
September 2, 2022
Toronto, ON (PRWEB) September 02, 2022 -- Stay on top of current hot topics through free webinars presented by leading experts in the pharma, biotech, medical
August 30, 2022
Toronto, ON (PRWEB) August 30, 2022 -- Register now to reserve your seat for this multidisciplinary virtual roundtable on advances in clinical trial endpoints